The relationship between COVID-19 infection and intracranial hemorrhage : A systematic review
© 2021 International Hemorrhagic Stroke Association. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)..
INTRODUCTION: In addition to the deleterious effects Covid-19 has on the pulmonary and cardiovascular systems, COVID-19 can also result in damage to the nervous system. This review aims to explore current literature on the association between COVID-19 and intracranial hemorrhage (ICH).
METHODS: We conducted a systematic review of PubMed for literature published on COVID-19 and ICH. Ninety-four of 295 screened papers met inclusion criteria.
RESULTS: The literature addressed incidence and mortality of ICH associated with Covid-19. It also revealed cases of COVID-19 patients with subarachnoid hemorrhage, intraparenchymal hemorrhage, subdural hematomas, and hemorrhage secondary to cerebral venous thrombosis and ischemic stroke. ICH during COVID-19 infections was associated with increased morbidity and mortality. Risk factors for ICH appeared to be therapeutic anticoagulation, ECMO, and mechanical ventilation. Outcomes varied widely, depending on the severity of COVID-19 infection and neurologic injury.
CONCLUSION: Although treatment for severe Covid-19 infections is often aimed at addressing acute respiratory distress syndrome, vasculopathy, and coagulopathy, neurologic injury can also occur. Evidence-based treatments that improve COVID-19 mortality may also increase risk for developing ICH. Providers should be aware of potential neurologic sequelae of COVID-19, diagnostic methods to rule out other causes of ICH, and treatment regimens.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:2 |
---|---|
Enthalten in: |
Brain hemorrhages - 2(2021), 4 vom: 17. Dez., Seite 141-150 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Daly, Samuel R [VerfasserIn] |
---|
Links: |
---|
Themen: |
Cerebral Venous Sinus Thrombosis |
---|
Anmerkungen: |
Date Revised 21.07.2023 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.1016/j.hest.2021.11.003 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM333242300 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM333242300 | ||
003 | DE-627 | ||
005 | 20231225221244.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.hest.2021.11.003 |2 doi | |
028 | 5 | 2 | |a pubmed24n1110.xml |
035 | |a (DE-627)NLM333242300 | ||
035 | |a (NLM)34786548 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Daly, Samuel R |e verfasserin |4 aut | |
245 | 1 | 4 | |a The relationship between COVID-19 infection and intracranial hemorrhage |b A systematic review |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 21.07.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a © 2021 International Hemorrhagic Stroke Association. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). | ||
520 | |a INTRODUCTION: In addition to the deleterious effects Covid-19 has on the pulmonary and cardiovascular systems, COVID-19 can also result in damage to the nervous system. This review aims to explore current literature on the association between COVID-19 and intracranial hemorrhage (ICH) | ||
520 | |a METHODS: We conducted a systematic review of PubMed for literature published on COVID-19 and ICH. Ninety-four of 295 screened papers met inclusion criteria | ||
520 | |a RESULTS: The literature addressed incidence and mortality of ICH associated with Covid-19. It also revealed cases of COVID-19 patients with subarachnoid hemorrhage, intraparenchymal hemorrhage, subdural hematomas, and hemorrhage secondary to cerebral venous thrombosis and ischemic stroke. ICH during COVID-19 infections was associated with increased morbidity and mortality. Risk factors for ICH appeared to be therapeutic anticoagulation, ECMO, and mechanical ventilation. Outcomes varied widely, depending on the severity of COVID-19 infection and neurologic injury | ||
520 | |a CONCLUSION: Although treatment for severe Covid-19 infections is often aimed at addressing acute respiratory distress syndrome, vasculopathy, and coagulopathy, neurologic injury can also occur. Evidence-based treatments that improve COVID-19 mortality may also increase risk for developing ICH. Providers should be aware of potential neurologic sequelae of COVID-19, diagnostic methods to rule out other causes of ICH, and treatment regimens | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Cerebral Venous Sinus Thrombosis | |
650 | 4 | |a Cerebral Venous Thrombosis | |
650 | 4 | |a Covid-19 | |
650 | 4 | |a Hemorrhagic Infarct | |
650 | 4 | |a Intracranial Hemorrhage | |
650 | 4 | |a Intraparenchymal Hemorrhage | |
650 | 4 | |a SARS-CoV-2 | |
650 | 4 | |a Subarachnoid Hemorrhage | |
700 | 1 | |a Nguyen, Anthony V |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Yilu |e verfasserin |4 aut | |
700 | 1 | |a Feng, Dongxia |e verfasserin |4 aut | |
700 | 1 | |a Huang, Jason H |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Brain hemorrhages |d 2020 |g 2(2021), 4 vom: 17. Dez., Seite 141-150 |w (DE-627)NLM317922505 |x 2589-238X |7 nnns |
773 | 1 | 8 | |g volume:2 |g year:2021 |g number:4 |g day:17 |g month:12 |g pages:141-150 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.hest.2021.11.003 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 2 |j 2021 |e 4 |b 17 |c 12 |h 141-150 |